Reported May 3, 2023 · Ongoing
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC…
Northwind Pharmaceuticals LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Northwind Pharmaceuticals LLC · 4838 Fletcher Ave Ste 1000 · Indianapolis, IN · 46203-1642
Is this the product you have?
- Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only
- Repackaged ByNorthwind Pharmaceuticals, Indianapolis, IN 46203
- Lot codes and dates
a) Lot #: F106252201Exp. Date 09/30/2024F106252301F106252303Exp. Date 5/31/2025F106252304Exp. Date 07/31/2025 b) Lot #: F106252302Exp. Date 07/31/2025
- Amount recalled
- a) 230 bottles; b) 22 bottles
This recall covers 7 products
The agency filed one notice per product. You are reading one of them; the other 6 are below.
Where it was sold
- Nationwide
Why it was recalled
CGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Northwind Pharmaceuticals LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.